BRIDGEWATER, N.J., Nov 4, 2025 – Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) today announced that it has been recognized by BioSpace as one of the 2026 Best Places to Work.
BioSpace, a leading source for life sciences news and careers, annually honors 50 U.S. employers that are viewed as the most desirable in the industry. Amneal was named among the top five large employers for the first time, reflecting the Company’s growing reputation and impact within the life sciences community.
Now in its fifth year, the BioSpace Best Places to Work list recognizes companies that demonstrate excellence in workplace culture, employee engagement, career development, leadership and innovation. The rankings are determined through feedback and ratings from thousands of life sciences professionals, underscoring Amneal’s continued commitment to creating an engaging and purpose-driven workplace.
Amneal’s culture is grounded in its mission of Making Healthy Possible and built on core values of integrity, collaboration, and shared ownership. The Company invests in its people through in-house leadership and development programs such as Amneal Leadership Lab (focused on leadership excellence) and My Amneal Career (focused on career growth), as well as ongoing employee engagement initiatives through Amneal Listens. Together, these programs foster belonging, purpose, and long-term professional growth across Amneal’s global workforce.
“We’re incredibly proud to be recognized by BioSpace as one of the industry’s Best Places to Work,” said Nikita Shah, Executive Vice President, Chief Human Resources Officer. “This award reflects our people-first culture and our shared commitment to making Amneal a place where talented, passionate individuals can grow, thrive, and make a difference.”
About Amneal
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX), headquartered in Bridgewater, NJ, is a global biopharmaceutical company. We make healthy possible through the development, manufacturing, and distribution of a diverse portfolio of over 290 pharmaceuticals, primarily within the United States. In its Affordable Medicines segment, the Company is expanding across a broad range of complex product categories and therapeutic areas, including injectables and biosimilars. In its Specialty segment, Amneal has a growing portfolio of branded pharmaceuticals focused primarily on central nervous system and endocrine disorders. Through its AvKARE segment, the Company is a distributor of pharmaceuticals and other products for the U.S. federal government, retail, and institutional markets. For more information, please visit www.amneal.com and follow us on LinkedIn.
About BioSpace
BioSpace is a leading source for life sciences news, career insights, and industry analysis. Through its annual Best Places to Work list, BioSpace recognizes companies that exemplify excellence in workplace culture, innovation, and employee engagement.
Media Contact
Brandon Skop
Sr. Director, Corporate Communications
brandon.skop@amneal.com